Literature DB >> 1554795

Therapeutic ranges for oral anticoagulation in different thromboembolic disorders.

L Poller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554795     DOI: 10.1007/bf01715345

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  36 in total

1.  AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL.

Authors:  E RICE-WRAY
Journal:  Br Med J       Date:  1964-10-03

2.  Anticoagulants in acute myocardial infarction.

Authors:  T HILDEN; K IVERSEN; F RAASCHOU; M SCHWARTZ
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

Review 3.  Hemorrhagic complications of long-term anticoagulant therapy.

Authors:  M N Levine; G Raskob; J Hirsh
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

4.  Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.

Authors:  D A Taberner; L Poller; R W Burslem; J B Jones
Journal:  Br Med J       Date:  1978-02-04

5.  Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction.

Authors:  A Drapkin; C Merskey
Journal:  JAMA       Date:  1972-10-30       Impact factor: 56.272

6.  A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group.

Authors: 
Journal:  Lancet       Date:  1980-11-08       Impact factor: 79.321

7.  Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.

Authors: 
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

8.  Protein C and the development of skin necrosis during anticoagulant therapy.

Authors:  A W Broekmans; R M Bertina; E A Loeliger; V Hofmann; H G Klingemann
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

9.  Questions and answers on prothrombin time standardisation in oral anticoagulant control.

Authors:  E A Loeliger; L Poller; M Samama; J M Thomson; A M Van den Besselaar; J Vermylen; M Verstraete
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

10.  Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

Authors:  J N Saour; J O Sieck; L A Mamo; A S Gallus
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.